The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
Pharmacogenetics of Opioids
Abstract
Opioids are used for acute and chronic pain and dependency. They have a narrow therapeutic index and large interpatient variability in response. Genetic factors regulating their pharmacokinetics (metabolizing enzymes, transporters) and pharmacodynamics (receptors and signal transduction elements) are contributors to such variability. The polymorphic CYP2D6 regulates the O-demethylation of codeine and other weak opioids to more potent metabolites with poor metabolizers having reduced antinociception in some cases. Some opioids are P-glycoprotein substrates, whereas, ABCB1 genotypes inconsistently influence opioid pharmacodynamics and dosage requirements. Single-nucleotide polymorphisms in the mu opioid receptor gene are associated with increasing morphine, but not methadone dosage requirements and altered efficacy of mu opioid agonists and antagonists. As knowledge regarding the interplay between genes affecting opioid pharmacokinetics including cerebral kinetics and pharmacodynamics increases, our understanding of the role of pharmacogenomics in mediating interpatient variability in efficacy and side effects to this important class of drugs will be better informed. Opioid drugs as a group have withstood the test of time in their ability to attenuate acute and chronic pain. Since the isolation of morphine in the early 1800s by Friedrich Sertürner, a large number of opioid drugs beginning with modification of the 4,5-epoxymorphinan ring structure were developed in order to improve their therapeutic margin, including reducing dependence and tolerance, ultimately without success.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mammalian ABC Transporters in Health and Disease
Borst, P., & Elferink, R. O. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.102301.093055 · Cited by 1,571
Diatchenko, L., Slade, G. D., Nackley, A. G., Bhalang, K., Sigurdsson, A., Belfer, I., Goldman, D., Xu, K., Shabalina, S. A., Shagin, D., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi013 · Cited by 1,280
COMT val 158 met Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain Stressor
Zubieta, J.-K., Heitzeg, M. M., Smith, Y. R., Bueller, J. A., Xu, K., Xu, Y., Koeppe, R. A., Stohler, C. S., & Goldman, D. (2003) · Science · doi:10.1126/science.1078546 · Cited by 1,125
Bond, C., LaForge, K. S., Tian, M., Melia, D., Zhang, S., Borg, L., Gong, J., Schluger, J., Strong, J. A., Leal, S. M., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9608 · Cited by 1,074
Identification of functionally variant MDR1 alleles among European Americans and African Americans
Kim, R. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.117412 · Cited by 1,009
Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry
Zanger, U. M., Raimundo, S., & Eichelbaum, M. (2004) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-003-0832-2 · Cited by 795
König, J., Nies, A. T., Cui, Y., Leier, I., & Keppler, D. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00169-8 · Cited by 791
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 723
Codeine Intoxication Associated with Ultrarapid CYP2D6 Metabolism
Gasche, Y., Daali, Y., Fathi, M., Chiappe, A., Cottini, S., Dayer, P., & Desmeules, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041888 · Cited by 702
Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother
Koren, G., Cairns, J., Chitayat, D., Gaedigk, A., & Leeder, S. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69255-6 · Cited by 684
Hoffmeyer, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050585397 · Cited by 599
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
Chan, L. M. S., Lowes, S., & Hirst, B. H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.07.003 · Cited by 582
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571
Allelic Expression Imbalance of Human mu Opioid Receptor (OPRM1) Caused by Variant A118G
Zhang, Y., Wang, D., Johnson, A. D., Papp, A. C., & Sadée, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504942200 · Cited by 563
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence
Tegeder, I., Costigan, M., Griffin, R. S., Abele, A., Belfer, I., Schmidt, H., Ehnert, C., Nejim, J., Marian, C., Scholz, J., et al. (2006) · Nature Medicine · doi:10.1038/nm1490 · Cited by 548
The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans
Mogil, J. S., Wilson, S. G., Chesler, E. J., Rankin, A. L., Nemmani, K. V. S., Lariviere, W. R., Groce, M. K., Wallace, M. R., Kaplan, L., Staud, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730053100 · Cited by 527
Transporters as a determinant of drug clearance and tissue distribution
Shitara, Y., Horie, T., & Sugiyama, Y. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.12.003 · Cited by 496
Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability
Wang, D., Johnson, A. D., Papp, A. C., Kroetz, D. L., & Sadée, W. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000178311.02878.83 · Cited by 490
Human UGT2B7 catalyzes morphine glucuronidation.
Coffman, B. L., Rios, G. R., King, C. D., & Tephly, T. R. (1997) · PubMed · Cited by 481
Bollinger, G. K. (1975) · Cited by 440
Kroetz, D. L., Pauli-Magnus, C., Hodges, L. M., Huang, C. C., Kawamoto, M., Johns, S. J., Stryke, D., Ferrin, T. E., DeYoung, J., Taylor, T., et al. (2003) · Pharmacogenetics · doi:10.1097/00008571-200308000-00006 · Cited by 429
Kullak-Ublick, G. A., Hagenbuch, B., Stieger, B., Schteingart, C. D., Hofmann, A. F., Wolkoff, A. W., & Meier, P. J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90588-x · Cited by 428
Kim, H., Neubert, J. K., San Miguel, A., Xu, K., Krishnaraju, R. K., Iadarola, M. J., Goldman, D., & Dionne, R. A. (2004) · Pain · doi:10.1016/j.pain.2004.02.027 · Cited by 428
Increased drug delivery to the brain by P-glycoprotein inhibition
Sadeque, A. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109156 · Cited by 426
LALOVIC, B., KHARASCH, E., HOFFER, C., RISLER, L., LIUCHEN, L., & SHEN, D. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.009 · Cited by 413
Gao, B., Hagenbuch, B., Kullak-Ublick, G. A., Benke, D., Aguzzi, A., & Meier, P. J. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39041-x · Cited by 412
Ameyaw, M.-M., Regateiro, F., Li, T., Liu, X., Tariq, M., Mobarek, A., Thornton, N., Folayan, G. O., Githang'a, J., Indalo, A., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200104000-00005 · Cited by 409
Iversen, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90876-5 · Cited by 390
The hypoalgesic effect of tramadol in relation to CYP2D6*
Poulsen, L., Arendt-Nielsen, L., Brøsen, K., & Sindrup, S. H. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90211-8 · Cited by 386
Klepstad, P., Rakvåg, T. T., Kaasa, S., Holthe, M., Dale, O., Borchgrevink, P. C., Baar, C., Vikan, T., Krokan, H. E., & Skorpen, F. (2004) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2004.00517.x · Cited by 381
Nies, A. T., Jedlitschky, G., König, J., Herold-Mende, C., Steiner, H. H., Schmitt, H.-P., & Keppler, D. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.051 · Cited by 379
Hitzl, M., Drescher, S., van der Kuip, H., Schäffeler, E., Fischer, J., Schwab, M., Eichelbaum, M., & Fromm, M. F. (2001) · Pharmacogenetics · doi:10.1097/00008571-200106000-00003 · Cited by 374
Catechol- O -methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli
Diatchenko, L., Nackley, A. G., Slade, G. D., Bhalang, K., Belfer, I., Max, M. B., Goldman, D., & Maixner, W. (2006) · Pain · doi:10.1016/j.pain.2006.05.024 · Cited by 372
Polymorphisms in Human Organic Anion-transporting Polypeptide 1A2 (OATP1A2)
Lee, W., Glaeser, H., Smith, L. H., Roberts, R. L., Moeckel, G. W., Gervasini, G., Leake, B. F., & Kim, R. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411092200 · Cited by 365
Expression and function of efflux drug transporters in the intestine
Takano, M., Yumoto, R., & Murakami, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.005 · Cited by 356
Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs
Cascorbi, I. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.04.009 · Cited by 355
Rakvåg, T. T., Klepstad, P., Baar, C., Kvam, T.-M., Dale, O., Kaasa, S., Krokan, H. E., & Skorpen, F. (2005) · Pain · doi:10.1016/j.pain.2005.03.032 · Cited by 347
Impact of CYP2D6 genotype on postoperative tramadol analgesia
Stamer, U. M., Lehnen, K., Höthker, F., Bayerer, B., Wolf, S., Hoeft, A., & Stuber, F. (2003) · Pain · doi:10.1016/s0304-3959(03)00212-4 · Cited by 333
Coffman, B. L., King, C. D., Rios, G. R., & Tephly, T. R. (1998) · PubMed · Cited by 322
Abram, S. E. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70202-x · Cited by 318
ABC of oral bioavailability: transporters as gatekeepers in the gut
Dietrich, C. G., Geier, A., & Oude Elferink, R. P. J. (2003) · Gut · doi:10.1136/gut.52.12.1788 · Cited by 317
Modulation of steady‐state kinetics of digoxin by haplotypes of the P‐glycoprotein MDR1 gene
Johne, A., Köpke, K., Gerloff, T., Mai, I., Rietbrock, S., Meisel, C., Hoffmeyer, S., Kerb, R., Fromm, M. F., Brinkmann, U., et al. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.129196 · Cited by 306
Frequency of C3435T polymorphism of MDR1 gene in African people
Schaeffeler, E., Eichelbaum, M. F., Brinkmann, U., Penger, A., Asante-Poku, S., Zanger, U. M., & Schwab, M. G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05579-9 · Cited by 281
Tissue Distribution and Induction of Human Multidrug Resistant Protein 3
Scheffer, G. L., Kool, M., de Haas, M., de Vree, J. M. L., Pijnenborg, A. C. L. M., Bosman, D. K., Oude Elferink, R. P. J., van der Valk, P., Borst, P., & Scheper, R. J. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780411 · Cited by 266
Beyer, A., Koch, T., Schröder, H., Schulz, S., & Höllt, V. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02340.x · Cited by 258
Eckhardt, K., Li, S., Ammon, S., Schänzle, G., Mikus, G., & Eichelbaum, M. (1998) · Pain · doi:10.1016/s0304-3959(98)00021-9 · Cited by 258
Williams, D. G., Patel, A., & Howard, R. F. (2002) · British Journal of Anaesthesia · doi:10.1093/bja/aef284 · Cited by 254
Court, M. H., Krishnaswamy, S., Hao, Q., Duan, S. X., Patten, C. J., von Moltke, L. L., & Greenblatt, D. J. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.9.1125 · Cited by 251
Melanocortin-1 receptor gene variants affect pain and μ-opioid analgesia in mice and humans
Mogil, J. S., Ritchie, J., Smith, S. B., Strasburg, K., Kaplan, L., Wallace, M. R., Romberg, R. R., Bijl, H., Sarton, E. Y., Fillingim, R. B., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.027698 · Cited by 249
Environmental and genetic factors associated with morphine response in the postoperative period
COULBAULT, L., BEAUSSIER, M., VERSTUYFT, C., WEICKMANS, H., DUBERT, L., TREGOUET, D., DESCOT, C., PARC, Y., LIENHART, A., & JAILLON, P. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.01.007 · Cited by 248
Wand, G. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00294-9 · Cited by 246
Siegsmund, M., Brinkmann, U., Scha[Combining Acute Accent]ffeler, E., Weirich, G., Schwab, M., Eichelbaum, M., Fritz, P., Burk, O., Decker, J., Alken, P., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019412.87412.bc · Cited by 246
Bhasker, C. R., McKinnon, W., Stone, A., Lo, A. C., Kubota, T., Ishizaki, T., & Miners, J. O. (2000) · Pharmacogenetics · doi:10.1097/00008571-200011000-00002 · Cited by 245
Aubrun, F., Langeron, O., Quesnel, C., Coriat, P., & Riou, B. (2003) · Anesthesiology · doi:10.1097/00000542-200306000-00017 · Cited by 243
Befort, K., Filliol, D., Décaillot, F. M., Gavériaux-Ruff, C., Hoehe, M. R., & Kieffer, B. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006352200 · Cited by 242
Impact of environmental and genetic factors on codeine analgesia
Desmeules, J., Gascon, M.-P., Dayer, P., & Magistris, M. (1991) · European Journal of Clinical Pharmacology · doi:10.1007/bf00280101 · Cited by 238
KHARASCH, E., HOFFER, C., WHITTINGTON, D., & SHEFFELS, P. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.05.003 · Cited by 238
Heritability of nociception II. ‘Types’ of nociception revealed by genetic correlation analysis
Mogil, J. S., Wilson, S. G., Bon, K., Eun Lee, S., Chung, K., Raber, P., Pieper, J. O., Hain, H. S., Belknap, J. K., Hubert, L., et al. (1999) · Pain · doi:10.1016/s0304-3959(98)00196-1 · Cited by 237
Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects
Ito, S., Ieiri, I., Tanabe, M., Suzuki, A., Higuchi, S., & Otsubo, K. (2001) · Pharmacogenetics · doi:10.1097/00008571-200103000-00008 · Cited by 234
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment
CRETTOL, S., DEGLON, J., BESSON, J., CROQUETTEKROKKAR, M., GOTHUEY, I., HAMMIG, R., MONNAT, M., HUTTEMANN, H., BAUMANN, P., & EAP, C. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.08.011 · Cited by 228
Stereoselective metabolism of methadone N‐demethylation by cytochrome P4502B6 and 2C19
Gerber, J. G., Rhodes, R. J., & Gal, J. (2004) · Chirality · doi:10.1002/chir.10303 · Cited by 228
Iribarne, C., Berthou, F., Baird, S., Dréano, Y., Picart, D., Bail, J. P., Beaune, P., & Ménez, J. F. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950116m · Cited by 227
Skarke, C., Darimont, J., Schmidt, H., Geisslinger, G., & Lötsch, J. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.5 · Cited by 226
Pharmacokinetic and Pharmacodynamic Implications of P‐glycoprotein Modulation
Matheny, C. J., Lamb, M. W., Brouwer, K. L. R., & Pollack, G. M. (2001) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.9.778.34558 · Cited by 222
Variable modulation of opioid brain uptake by P-glycoprotein in mice
Dagenais, C., Graff, C. L., & Pollack, G. M. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.027 · Cited by 220
Implications of genetic polymorphisms in drug transporters for pharmacotherapy
Kerb, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.06.051 · Cited by 219
Meier, Y., Pauli-Magnus, C., Zanger, U. M., Klein, K., Schaeffeler, E., Nussler, A. K., Nussler, N., Eichelbaum, M., Meier, P. J., & Stieger, B. (2006) · Hepatology · doi:10.1002/hep.21214 · Cited by 219
Wandel, C., Kim, R., Wood, M., & Wood, A. (2002) · Anesthesiology · doi:10.1097/00000542-200204000-00019 · Cited by 215
Lötsch, J., Skarke, C., Grösch, S., Darimont, J., Schmidt, H., & Geisslinger, G. (2002) · Pharmacogenetics · doi:10.1097/00008571-200201000-00002 · Cited by 211
King, M., Su, W., Chang, A., Zuckerman, A., & Pasternak, G. W. (2001) · Nature Neuroscience · doi:10.1038/85115 · Cited by 209
Siegmund, W., Ludwig, K., Giessmann, T., Dazert, P., Schroeder, E., Sperker, B., Warzok, R., Kroemer, H. K., & Cascorbi, I. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127739 · Cited by 199
Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract
Thörn, M., Finnström, N., Lundgren, S., Rane, A., & Lööf, L. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02389.x · Cited by 196
Sindrup, S. H., Brøsen, K., Bjerring, P., Arendt-Nielsen, L., Larsen, U., Angelo, H. R., & Gram, L. F. (1990) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1990.212 · Cited by 194
Subrahmanyam, V. V., Renwick, A. B., Walters, D. G., Young, P. J., Price, R. J., Tonelli, A. P., & Lake, B. G. (2001) · PubMed · Cited by 190
Letschert, K., Keppler, D., & König, J. (2004) · Pharmacogenetics · doi:10.1097/01.fpc.0000114744.08559.92 · Cited by 187
Foster, D. J. R., Somogyi, A. A., & Bochner, F. (1999) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1999.00921.x · Cited by 179
Self-citationSawyer, M. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00053-5 · Cited by 177
Pharmacogenetic determination of the effects of codeine and prediction of drug interactions.
Caraco, Y., Sheller, J., & Wood, A. J. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20766-2 · Cited by 176
Maddocks, I., Somogyi, A., Abbott, F., Hayball, P., & Parker, D. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(96)00050-4 · Cited by 169
Self-citationClinical Relevance of P-Glycoprotein in Drug Therapy
Lin, J. H., & Yamazaki, M. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026871 · Cited by 167
Romberg, R. R., Olofsen, E., Bijl, H., Taschner, P. E. M., Teppema, L. J., Sarton, E. Y., van Kleef, J. W., & Dahan, A. (2005) · Anesthesiology · doi:10.1097/00000542-200503000-00008 · Cited by 166
Holthe, M., Rakvåg, T. N., Klepstad, P., Idle, J. R., Kaasa, S., Krokan, H. E., & Skorpen, F. (2003) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500139 · Cited by 163
How individual sensitivity to opiates can be predicted by gene analyses
Ikeda, K., Ide, S., Han, W., Hayashida, M., Uhl, G. R., & Sora, I. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.04.001 · Cited by 161
Lötsch, J., Zimmermann, M., Darimont, J., Marx, C., Dudziak, R., Skarke, C., & Geißlinger, G. (2002) · Anesthesiology · doi:10.1097/00000542-200210000-00011 · Cited by 155
Cellular localization and regional distribution of CYP2D6 mRNA and protein expression in human brain
Siegle, I., Fritz, P., Eckhardt, K., Zanger, U. M., & Eichelbaum, M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200104000-00007 · Cited by 153
Oertel, B. G., Schmidt, R., Schneider, A., Geißlinger, G., & Lötsch, J. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000220566.90466.a2 · Cited by 152
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals
Coller, J. K., Barratt, D. T., Dahlen, K., LOENNECHEN, M., & Somogyi, A. A. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.011 · Cited by 151
Self-citationINVOLVEMENT OF CYP3A4, CYP2C8, AND CYP2D6 IN THE METABOLISM OF (R)- AND (S)-METHADONE IN VITRO
Wang, J.-S., & DeVane, C. L. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.6.742 · Cited by 150
The metabolism of tramadol by human liver microsomes
Paar, W. D., Frankus, P., & Dengler, H. J. (1992) · Journal of Molecular Medicine · doi:10.1007/bf00180294 · Cited by 149
Are μ-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch, J., & Geißlinger, G. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.006 · Cited by 146
Hutchinson, M. R., Menelaou, A., Foster, D. J. R., Coller, J. K., & Somogyi, A. A. (2004) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.02002.x · Cited by 144
Self-citationRomberg, R. R., Olofsen, E., Sarton, E. Y., den Hartigh, J., Taschner, P. E. M., & Dahan, A. (2003) · Anesthesiology · doi:10.1097/00000542-200401000-00021 · Cited by 143
Hitzl, M., Schaeffeler, E., Hocher, B., Slowinski, T., Halle, H., Eichelbaum, M. F., Kaufmann, P., Fritz, P., Fromm, M. F., & Schwab, M. G. (2004) · Pharmacogenetics · doi:10.1097/00008571-200405000-00006 · Cited by 137
Chen, Z., Somogyi, A., Reynolds, G., & Bochner, F. (1991) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1991.tb05550.x · Cited by 136
Self-citationSaito, S., Iida, A., Sekine, A., Miura, Y., Ogawa, C., Kawauchi, S., Higuchi, S., & Nakamura, Y. (2002) · Journal of Human Genetics · doi:10.1007/s100380200018 · Cited by 135
Codeine O‐demethylation co‐segregates with polymorphic debrisoquine hydroxylation.
Yue, Q.-Y., Svensson, J., Alm, C., et al. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03556.x · Cited by 134
van Holthe, M. S. T., Klepstad, P., Zahlsen, K., Borchgrevink, P. C., Hagen, L., Dale, O., Kaasa, S., Krokan, H. E., & Skorpen, F. (2002) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-002-0490-1 · Cited by 133
Lang, T., Klein, K., Richter, T., Zibat, A., Kerb, R., Eichelbaum, M. F., Schwab, M. G., & Zanger, U. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068973 · Cited by 133
Current evidence for a genetic modulation of the response to analgesics
Lötsch, J., & Geißlinger, G. (2006) · Pain · doi:10.1016/j.pain.2006.01.010 · Cited by 132
Enggaard, T. P., Poulsen, L. K., Arendt‐Nielsen, L., Brøsen, K., Ossig, J., & Sindrup, S. H. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000189613.61910.32 · Cited by 126
Belfer, I., Wu, T., Kingman, A., Krishnaraju, R. K., Goldman, D. A., Max, M. B., & Warltier, D. C. (2004) · Anesthesiology · doi:10.1097/00000542-200406000-00032 · Cited by 124
Chowbay, B., Li, H., Machin, D., Cheung, Y. B., & Lee, E. J. D. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02392.x · Cited by 119
Increased brain P-glycoprotein in morphine tolerant rats
Aquilante, C. L., Letrent, S. P., Pollack, G. M., & Brouwer, K. L. R. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00599-8 · Cited by 117
Lang, T., Hitzl, M., Burk, O., Mornhinweg, E., Keil, A., Kerb, R., Klein, K., Zanger, U. M., Eichelbaum, M. F., & Fromm, M. F. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00003 · Cited by 116
Cytochrome P450 2D6 Genotype and Methadone Steady-State Concentrations
Eap, C. B., Broly, F., Mino, A., Hämmig, R., Déglon, J. J., Uehlinger, C., Meili, D., Chevalley, A.-F., Bertschy, G., ZULLINO, D. F., et al. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00016 · Cited by 114
Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer
Susce, M. T., Murray-Carmichael, E., & de León, J. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.018 · Cited by 105
Løvlie, R., Daly, A. K., Matre, G. E., Molven, A., & Steen, V. M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200102000-00006 · Cited by 101
Laugesen, S., Enggaard, T. P., Pedersen, R. S., Sindrup, S. H., & Brøsen, K. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.11.002 · Cited by 100
Kharasch, E. D., Hoffer, C. J., & Whittington, D. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02053.x · Cited by 100
Plasma morphine and glucuronide (M3G and M6G) concentrations in hospice inpatients
Ashby, M., Fleming, B. G., Wood, M., et al. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00020-1 · Cited by 98
Caraco, Y., Sheller, J. R., & Wood, A. J. J. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34915-8 · Cited by 91
Begré, S., von Bardeleben, U., Ladewig, D., et al. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200204000-00017 · Cited by 90
Owen, A., Goldring, C. E., Morgan, P., Chadwick, D. W., Park, B. K., & Pirmohamed, M. (2005) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02229.x · Cited by 85
Kharasch, E. D., Hoffer, C. J., Altuntas, T. G., & Whittington, D. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003262075 · Cited by 84
Eap, C. B., Bertschy, G., Powell, K., et al. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704000-00010 · Cited by 80
The effect of food components on the absorption of P-gp substrates: a review
Deferme, S., & Augustijns, P. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235702603 · Cited by 79
Pharmacogenetics of opioid receptors and addiction
Mayer, P. E., & Höllt, V. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000182781.87932.0d · Cited by 77
Persson, K., Sjöström, S., Sigurdardottir, I., et al. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04428.x · Cited by 72
Oselin, K., Gashaw, I., Mrozikiewicz, P. M., Wolbergs, D., Pähkla, R., & Roots, I. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01133.x · Cited by 60
G2677T and C3435T Genotype and Haplotype Are Associated With HepaticABCB1(MDR1) Expression
Song, P., Lamba, J. K., Zhang, L., Schuetz, E. G., Shukla, N., Meibohm, B., & Yates, C. R. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005284387 · Cited by 56
Transport systems for opioid peptides in mammalian tissues
Ganapathy, V., & Miyauchi, S. (2005) · The AAPS Journal · doi:10.1208/aapsj070482 · Cited by 55
Contopoulos‐Ioannidis, D. G., Alexiou, G. Α., Gouvias, T. C., & Ioannidis, J. P. A. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000236332.11304.8f · Cited by 54
Yamada, H., Ishii, K., Ishii, Y., et al. (2003) · The Journal of Toxicological Sciences · doi:10.2131/jts.28.395 · Cited by 54
Webb, J. A., Rostami‐Hodjegan, A., Abdul‐Manap, R., Hofmann, U., Mikus, G., & Kamali, F. (2001) · British Journal of Clinical Pharmacology · doi:10.1046/j.0306-5251.2001.01414.x · Cited by 47
The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel
Crowe, A. P. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01366-3 · Cited by 47
Codeine in post-operative pain
Poulsen, L. K., Riishede, L., Brøsen, K., et al. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050491 · Cited by 44
Saito, K., Moriya, H., Sawaguchi, T., Hayakawa, T., Nakahara, S., Goto, A., Arimura, Y., Imai, K., Kurosawa, N., Owada, E., et al. (2006) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2006.01.002 · Cited by 39
Miotic action of tramadol is determined by CYP2D6 genotype
Slanař, O., Nobilis, M., Kvetina, J., Mikoviny, R., Zima, T., Idle, J. R., & Perlík, F. (2007) · Physiological Research · doi:10.33549/physiolres.930872 · Cited by 38
Opioids Bind to the Amino Acids 84 to 118 of UDP-Glucuronosyltransferase UGT2B7
Coffman, B. L., Kearney, W. R., Goldsmith, S., Knosp, B. M., & Tephly, T. R. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.283 · Cited by 32
Wang, H., Hao, B., Zhou, K., Chen, X., Wu, S., Zhou, G., Zhu, Y., & He, F. (2004) · Annals of Human Genetics · doi:10.1046/j.1529-8817.2003.00124.x · Cited by 28
Influence of CYP2D6 Genetics on Opioid Kinetics, Metabolism and Response
Mikus, G., & Weiß, J. (2005) · Current Pharmacogenomics · doi:10.2174/1570160053175018 · Cited by 27
Melichar, J., MYLES, J., Eap, C. B., & Nutt, D. (2003) · Addiction Biology · doi:10.1080/1355621031000069891 · Cited by 15
Relationship between 4,5-epoxymorphinan structure and in vitro modulation of cell proliferation
Hutchinson, M. R., & Somogyi, A. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.04.049 · Cited by 11
Self-citation
Cited by
Hudak, M. L., Tan, R. C., THE COMMITTEE ON DRUGS, THE COMMITTEE ON FETUS AND NEWBORN, Frattarelli, D. A. C., Galinkin, J. L., Green, T. P., Neville, K. A., Paul, I. M., Van Den Anker, J. N., et al. (2012) · Pediatrics · doi:10.1542/peds.2011-3212 · Cited by 877
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I
Zhou, S.-F. (2009) · Clinical Pharmacokinetics · doi:10.2165/11318030-000000000-00000 · Cited by 756
Treatment of acute postoperative pain
Wu, C. L., & Raja, S. N. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60245-6 · Cited by 628
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part II
Zhou, S.-F. (2009) · Clinical Pharmacokinetics · doi:10.2165/11318070-000000000-00000 · Cited by 330
Metadata
- Authors
- Somogyi, A. A., Barratt, D. T., & Coller, J. K.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2007-03
- Volume
- 81
- Issue
- 3
- Pages
- 429-444
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2107948836
- Cited by
- 324
- References
- 135
- FWCI
- 25.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.